Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy

Authors

Amber C. Streifel, Oregon Health & Science University
Katie Luis, Oregon Health & Science University
Monark Nakrani, Oregon Health & Science University
Diana Yu, Oregon Health & Science University
Monica K. Sikka, Oregon Health & Science University
Cara D. Varley, Portland State University
Alyse Douglass, Oregon Health & Science University
Heather Mayer, Oregon Health & Science University
Kathleen Young, Oregon Health & Science University
James S. Lewis II, Oregon Health & Science University

Published In

Open Forum Infectious Diseases

Document Type

Article

Publication Date

8-9-2024

Subjects

Health Research -- Public Health

Abstract

Vancomycin and daptomycin are frequently used in outpatient parenteral antimicrobial therapy (OPAT). We analyze health care utilization and cost to the health care system for vancomycin vs daptomycin in the outpatient setting and find that vancomycin results in significantly higher health care utilization and similar cost per course compared with daptomycin in OPAT.

Rights

Copyright (c) 2024 The Authors Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.

Locate the Document

https://doi.org/10.1093/ofid/ofae438

DOI

10.1093/ofid/ofae438

Persistent Identifier

https://archives.pdx.edu/ds/psu/42464

Citation Details

Streifel, A. C., Luis, K., Nakrani, M., Yu, D., Sikka, M. K., Varley, C. D., Douglass, A., Mayer, H., Young, K., & Lewis, J. S. (2024). Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy. Open Forum Infectious Diseases, 11(8).